Browse Category

NYSE:TWO News 17 December 2025 - 2 February 2026

UWM stock jumps nearly 9% as Two Harbors earnings near and merger math tightens

UWM stock jumps nearly 9% as Two Harbors earnings near and merger math tightens

UWM Holdings shares rose 8.6% to $5.33 by midday Monday after closing at $4.91, ahead of Two Harbors’ quarterly earnings report due after the bell. UWM last week filed a Form S-4 for its planned $1.3 billion stock-for-stock acquisition of Two Harbors. Two Harbors shares gained 7.5%. The deal’s value depends on UWM’s share price and awaits shareholder and regulatory approval.
UWM Holdings stock (UWMC) jumps 14% on Trump’s $200 billion mortgage-bond order — what’s next

UWM Holdings stock (UWMC) jumps 14% on Trump’s $200 billion mortgage-bond order — what’s next

UWM Holdings shares jumped 13.7% to $5.36 Friday after President Trump announced a $200 billion mortgage bond purchase program. The move sparked rallies in mortgage and housing stocks. UWM’s NYSE-listed warrants are being delisted, according to a Form 25 filing. The company’s $1.3 billion acquisition of Two Harbors Investment is pending, with closure expected in Q2 2026.
TWO-PA Stock News Today (Dec. 17, 2025): UWM’s $1.3B Two Harbors Deal Puts Series A Preferred in Focus — What Holders Need to Know

TWO-PA Stock News Today (Dec. 17, 2025): UWM’s $1.3B Two Harbors Deal Puts Series A Preferred in Focus — What Holders Need to Know

Two Harbors Investment Corp.’s Series A fixed-to-floating preferred stock — commonly shown by brokers and data vendors as TWO-PA, TWO.PRA, or TWO PRA — is drawing unusual attention on December 17, 2025 after a major corporate action: UWM Holdings Corporation (NYSE: UWMC) and Two Harbors Investment Corp. (NYSE: TWO) announced a definitive agreement for UWM to acquire Two Harbors in an all-stock transaction valued at about $1.3 billion. SEC+1 For preferred holders, the headline detail is clear and highly material: each share of Two Harbors’ Series A preferred stock will be exchanged for one share of a newly issued UWM
TWO-PB Stock Today: Two Harbors Series B Preferred Jumps After UWM’s $1.3B Acquisition Deal — Dividend Outlook, Exchange Terms, and Key Risks

TWO-PB Stock Today: Two Harbors Series B Preferred Jumps After UWM’s $1.3B Acquisition Deal — Dividend Outlook, Exchange Terms, and Key Risks

Two Harbors Investment Corp.’s Series B preferred stock — commonly quoted as TWO-PB (also seen as TWO-B or TWO.PRB) — is in sharp focus on December 17, 2025, after a blockbuster corporate event changed how income investors are thinking about the security’s credit outlook and “change-of-control” mechanics. The headline catalyst: UWM Holdings Corp. (UWMC) and Two Harbors Investment Corp. (TWO) announced a definitive all-stock merger that values the transaction at about $1.3 billion, with Two Harbors common shareholders receiving a fixed exchange ratio of 2.3328 shares of UWMC Class A per share of TWO. investors.uwm.com+1 While most general-market coverage has

Stock Market Today

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
COPENHAGEN, February 7, 2026, 23:19 CET — Market closed. Novo Nordisk A/S Class B shares will be back in focus when trading resumes on Monday after telehealth firm Hims & Hers said it would stop offering access to a $49 compounded version of Novo’s Wegovy pill following U.S. regulatory warnings. Novo’s Copenhagen-listed shares ended Friday at 295.50 crowns, up 5.3%, according to Reuters market data. (Reuters) Why it matters now: the $49 offer put a fresh spotlight on how quickly cheaper, unapproved copies can spread in the fast-growing obesity-drug market — and how hard it may be for drugmakers to
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Go toTop